Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Todd Neale

February 18, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2024

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Presenter: David M. Kaye

March 05, 2024

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

News Conference News THT 2023

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

Shelley Wood

March 22, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

Presentation THT 2023

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Presenter: Sheldon Litwin

March 21, 2023

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Presentation THT 2022

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

Presenter: Barry Borlaug

February 01, 2022

Presentation THT 2022

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Presenter: Sanjiv Shah

February 01, 2022

Advertisement

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content